Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D321-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-10 |
filingDate |
2007-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cac38668bec1ffda1289ed3be75278a |
publicationDate |
2007-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
UY-30160-A1 |
titleOfInvention |
USE OF HETEROCICLIC SULFAMIDE DERIVATIVES FUSED WITH BENZO FOR MIGRANE TREATMENT |
abstract |
The present invention relates to a method for the treatment or prevention of migraine which comprises administering to a subject in need a therapeutically effective amount of one or more novel derivatives of benzo-fused heterocyclic sulfamide of the formula (I) and formula ( II) as defined in this invention. The present invention relates to a method for the treatment and / or prevention of migraine, which includes monotherapy and alternatively, therapy with at least one antimigrane agent. |
priorityDate |
2006-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |